Elizabeth Higgs
Overview
Explore the profile of Elizabeth Higgs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fallah M, Van Ryn C, Moses J, Badio M, Fayiah T, Johnson K, et al.
Lancet Microbe
. 2025 Mar;
:101033.
PMID: 40081398
Background: A high proportion of survivors of Ebola virus disease (EVD) have post-acute sequelae of EVD (PASE), but the relationship between inflammation and PASE pathogenesis is poorly understood. This study...
2.
Mourad A, Grandits G, Siegel L, Engen N, Barkauskas C, Eriobu N, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39922466
Objectives: Passive immunotherapy, including monoclonal antibodies and neutralizing proteins, was used for the treatment of patients with COVID-19 during the pandemic. Accelerating COVID-19 Therapeutic Interventions and Vaccines-Therapeutics for Inpatients with...
3.
Gulick R, Pau A, Daar E, Evans L, Gandhi R, Tebas P, et al.
Ann Intern Med
. 2024 Sep;
177(11):1547-1557.
PMID: 39348691
Description: In March 2020, the White House Coronavirus Task Force determined that clinicians in the United States needed expert treatment guidelines to optimally manage patients with COVID-19, a potentially life-threatening...
4.
Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, et al.
J Infect Dis
. 2024 Sep;
PMID: 39269490
Background: Biomarker guided therapy could improve management of COVID-19 inpatients. Although some results indicate that antibody tests are prognostic, little is known about patient management using point-of-care (POC) antibody tests....
5.
Kagan J, Wilson B, Touchette N, Cone K, Kiawu H, Cooper J, et al.
Prog Community Health Partnersh
. 2023 Nov;
15(3):337-347.
PMID: 37934421
Background: At the invitation of the Liberia Ministry of Health and Social Welfare (LMOHSW), the U.S. Department of Health and Human Services joined the LMOHSW in establishing the Partnership for...
6.
Drew C, Badio M, Dennis D, Hensley L, Higgs E, Sneller M, et al.
Biometrics
. 2022 May;
79(2):1546-1558.
PMID: 35531799
Many different methods for evaluating diagnostic test results in the absence of a gold standard have been proposed. In this paper, we discuss how one common method, a maximum likelihood...
7.
Murray D, Babiker A, Baker J, Barkauskas C, Brown S, Chang C, et al.
Clin Trials
. 2021 Oct;
19(1):52-61.
PMID: 34632800
Background/aims: Safe and effective therapies for COVID-19 are urgently needed. In order to meet this need, the Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership initiated the Therapeutics for Inpatients...
8.
Miller M, Skrzekut A, Kracalik I, Jones J, Lofy K, Konkle B, et al.
Transfusion
. 2021 Sep;
61(10):2814-2824.
PMID: 34510475
In March 2020, there were no treatment options for COVID-19. Passive immune therapy including anti-SARS-CoV-2 hyperimmune globulin (hIVIG) was a logical candidate for COVID-19 therapeutic trials, given past success treating...
9.
Bozman C, Fallah M, Sneller M, Freeman C, Fakoli 3rd L, Shobayo B, et al.
Emerg Infect Dis
. 2021 Mar;
27(4):1239-1241.
PMID: 33755000
Ebola virus RNA can reside for months or years in semen of survivors of Ebola virus disease and is probably associated with increased risk for cryptic sexual transmission of the...
10.
Wilson B, Wright K, Taylor R, Higgs E
Nat Med
. 2021 Mar;
27(3):369-371.
PMID: 33723450
No abstract available.